Cargando…

Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial

BACKGROUND: Epilepsy is the most common neurological problem that affects people with learning disabilities. The high seizure frequency, resistance to treatments, associated skills deficit and co-morbidities make the management of epilepsy particularly challenging for people with learning disabiliti...

Descripción completa

Detalles Bibliográficos
Autores principales: Durand, Marie-Anne, Gates, Bob, Parkes, Georgina, Zia, Asif, Friedli, Karin, Barton, Garry, Ring, Howard, Oostendorp, Linda, Wellsted, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289382/
https://www.ncbi.nlm.nih.gov/pubmed/25414095
http://dx.doi.org/10.1186/1745-6215-15-455
_version_ 1782352107104370688
author Durand, Marie-Anne
Gates, Bob
Parkes, Georgina
Zia, Asif
Friedli, Karin
Barton, Garry
Ring, Howard
Oostendorp, Linda
Wellsted, David
author_facet Durand, Marie-Anne
Gates, Bob
Parkes, Georgina
Zia, Asif
Friedli, Karin
Barton, Garry
Ring, Howard
Oostendorp, Linda
Wellsted, David
author_sort Durand, Marie-Anne
collection PubMed
description BACKGROUND: Epilepsy is the most common neurological problem that affects people with learning disabilities. The high seizure frequency, resistance to treatments, associated skills deficit and co-morbidities make the management of epilepsy particularly challenging for people with learning disabilities. The Books Beyond Words booklet for epilepsy uses images to help people with learning disabilities manage their condition and improve quality of life. Our aim is to conduct a randomized controlled feasibility trial exploring key methodological, design and acceptability issues, in order to subsequently undertake a large-scale randomized controlled trial of the Books Beyond Words booklet for epilepsy. METHODS/DESIGN: We will use a two-arm, single-centre randomized controlled feasibility design, over a 20-month period, across five epilepsy clinics in Hertfordshire, United Kingdom. We will recruit 40 eligible adults with learning disabilities and a confirmed diagnosis of epilepsy and will randomize them to use either the Books Beyond Words booklet plus usual care (intervention group) or to receive routine information and services (control group). We will collect quantitative data about the number of eligible participants, number of recruited participants, demographic data, discontinuation rates, variability of the primary outcome measure (quality of life: Epilepsy and Learning Disabilities Quality of Life scale), seizure severity, seizure control, intervention’s patterns of use, use of other epilepsy-related information, resource use and the EQ-5D-5L health questionnaire. We will also gather qualitative data about the feasibility and acceptability of the study procedures and the Books Beyond Words booklet. Ethical approval for this study was granted on 28 April 2014, by the Wales Research Ethics Committee 5. Recruitment began on 1 July 2014. DISCUSSION: The outcomes of this feasibility study will be used to inform the design and methodology of a definitive study, adequately powered to determine the impact of the Books Beyond Words intervention to improve the management of epilepsy in people with learning disabilities. TRIAL REGISTRATION: http://ISRCTN80067039 (Date of ISRCTN assignation: 23 April 2014).
format Online
Article
Text
id pubmed-4289382
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42893822015-01-11 Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial Durand, Marie-Anne Gates, Bob Parkes, Georgina Zia, Asif Friedli, Karin Barton, Garry Ring, Howard Oostendorp, Linda Wellsted, David Trials Study Protocol BACKGROUND: Epilepsy is the most common neurological problem that affects people with learning disabilities. The high seizure frequency, resistance to treatments, associated skills deficit and co-morbidities make the management of epilepsy particularly challenging for people with learning disabilities. The Books Beyond Words booklet for epilepsy uses images to help people with learning disabilities manage their condition and improve quality of life. Our aim is to conduct a randomized controlled feasibility trial exploring key methodological, design and acceptability issues, in order to subsequently undertake a large-scale randomized controlled trial of the Books Beyond Words booklet for epilepsy. METHODS/DESIGN: We will use a two-arm, single-centre randomized controlled feasibility design, over a 20-month period, across five epilepsy clinics in Hertfordshire, United Kingdom. We will recruit 40 eligible adults with learning disabilities and a confirmed diagnosis of epilepsy and will randomize them to use either the Books Beyond Words booklet plus usual care (intervention group) or to receive routine information and services (control group). We will collect quantitative data about the number of eligible participants, number of recruited participants, demographic data, discontinuation rates, variability of the primary outcome measure (quality of life: Epilepsy and Learning Disabilities Quality of Life scale), seizure severity, seizure control, intervention’s patterns of use, use of other epilepsy-related information, resource use and the EQ-5D-5L health questionnaire. We will also gather qualitative data about the feasibility and acceptability of the study procedures and the Books Beyond Words booklet. Ethical approval for this study was granted on 28 April 2014, by the Wales Research Ethics Committee 5. Recruitment began on 1 July 2014. DISCUSSION: The outcomes of this feasibility study will be used to inform the design and methodology of a definitive study, adequately powered to determine the impact of the Books Beyond Words intervention to improve the management of epilepsy in people with learning disabilities. TRIAL REGISTRATION: http://ISRCTN80067039 (Date of ISRCTN assignation: 23 April 2014). BioMed Central 2014-11-20 /pmc/articles/PMC4289382/ /pubmed/25414095 http://dx.doi.org/10.1186/1745-6215-15-455 Text en © Durand et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Durand, Marie-Anne
Gates, Bob
Parkes, Georgina
Zia, Asif
Friedli, Karin
Barton, Garry
Ring, Howard
Oostendorp, Linda
Wellsted, David
Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title_full Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title_fullStr Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title_full_unstemmed Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title_short Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial
title_sort wordless intervention for epilepsy in learning disabilities (wield): study protocol for a randomized controlled feasibility trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289382/
https://www.ncbi.nlm.nih.gov/pubmed/25414095
http://dx.doi.org/10.1186/1745-6215-15-455
work_keys_str_mv AT durandmarieanne wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT gatesbob wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT parkesgeorgina wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT ziaasif wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT friedlikarin wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT bartongarry wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT ringhoward wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT oostendorplinda wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial
AT wellsteddavid wordlessinterventionforepilepsyinlearningdisabilitieswieldstudyprotocolforarandomizedcontrolledfeasibilitytrial